查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1947901

全EXOME定序市場分析及預測（至2035年）：依類型、產品類型、服務、技術、應用、最終使用者、組件、功能及設備分類

Whole Exome Sequencing Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Component, Functionality, Device
出版日期: | 出版商: Global Insight Services | 英文 315 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全EXOME定序市場預計將從2024年的144億美元成長到2034年的903億美元，複合年成長率約為32.4%。全EXOME定序市場涵蓋對基因的整個蛋白質轉錄區（即EXOME）進行定序的技術和服務。該技術有助於識別與疾病相關的基因突變，並為個人化醫療提供重要資訊。測序技術的進步和成本的下降正在推動市場成長。基因組監測、罕見疾病診斷和精準腫瘤學研究的增加也推動了市場需求，凸顯了數據分析和解讀創新的必要性。

全EXOME序市場正經歷強勁成長，主要得益於基因組研究和個人化醫療的進步。服務板塊是市場成長的主要驅動力，其中診斷服務和臨床研究應用是核心。這主要歸功於全外顯子定序在識別遺傳疾病和製定治療策略方面的重要作用。產品板塊，尤其是試劑盒和試劑等耗材，緊隨其後，反映了市場對可靠高效測序流程的持續需求。在服務板塊中，臨床診斷預計將繼續保持領先地位，這主要得益於精準醫療需求的不斷成長。研究應用，尤其是在腫瘤學領域，是表現第二好的板塊，主要得益於對詳細遺傳資訊的需求。全EXOME定序在罕見疾病診斷中的日益普及進一步鞏固了其市場潛力。技術進步，例如定序準確性的提高和成本的降低，預計將維持市場成長勢頭，並為相關人員帶來盈利的機會。

市場區隔
類型 標靶EXOME定序、全EXOME顯子定序
產品 試劑盒、試劑、設備和軟體
服務 定序服務、數據分析服務、諮詢服務
科技 合成定定序、離子半導體定序、奈米定序
應用領域 診斷、藥物發現與開發、個人化醫療、農業與動物研究
最終用戶 醫院和診所、研究機構、製藥和生物技術公司、學術機構
成分 硬體、軟體和服務
功能 資料管理、資料解讀、資料存儲
裝置 桌上型音序器，可攜式音序器

受基因組技術和個人化醫療發展的影響，全EXOME定序市場正經歷市場佔有率的動態變化。定價策略競爭日益激烈，各公司力求在不犧牲品質的前提下提供具成本效益的解決方案。為了滿足日益成長的精準診斷需求，各公司不斷創新，新產品層出不窮。該市場以強大的次世代定序平台開發平臺為特徵，體現了對技術進步和提高可及性的不懈追求。全EXOME定序市場的競爭異常激烈，主要參與者透過策略聯盟和收購爭奪主導。監管政策影響顯著，嚴格的指導方針塑造了市場准入和營運標準。北美地區憑藉著有利的法規結構和大量的研發投入，仍然是該市場的關鍵區域。同時，在政府主導的舉措和不斷成長的醫療費用支出的推動下，亞太地區正崛起為一個充滿潛力的市場。生物資訊學的進步和臨床應用的拓展正在推動市場成長。

主要趨勢和促進因素：

全EXOME定序市場正經歷強勁成長，這主要得益於技術進步和定序成本的下降。這一趨勢使得更多研究機構和醫療服務提供者能夠更便捷地使用這項技術。此外，遺傳疾病的日益普遍以及對個人化醫療的需求，也推動了對更精準、更全面的基因分析的需求。另一個關鍵趨勢是將人工智慧 (AI) 和機器學習技術應用於數據分析。這些技術能夠增強對複雜基因數據的解讀，並提供有助於開發更有效治療方案的見解。此外，學術機構與產業界的合作正在促進創新，並加速新型定序解決方案的發展。對罕見疾病研究的日益關注也是一個促進因素，因為全外EXOME定序為識別基因突變提供了強大的工具。隨著醫療基礎設施的改善和人們對先進基因檢測興趣的成長，發展中地區也湧現出新的機會。能夠提供經濟高效且擴充性解決方案的公司將佔據有利地位，贏得市場佔有率。隨著人們對基因檢測益處的認知不斷提高，預計該市場將繼續擴張。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 標靶EXOME定序
    • 全外EXOME定序
    • 其他
  • 市場規模及預測：依產品分類
    • 成套工具
    • 試劑
    • 裝置
    • 軟體
    • 其他
  • 市場規模及預測：依服務分類
    • 定序服務
    • 數據分析服務
    • 諮詢服務
    • 其他
  • 市場規模及預測：依技術分類
    • 合成定定序
    • 離子半導體定序
    • 奈米孔定序
    • 其他
  • 市場規模及預測：依應用領域分類
    • 診斷
    • 藥物發現與開發
    • 個人化醫療
    • 農業和畜牧業調查
    • 其他
  • 市場規模及預測：依最終用戶分類
    • 醫院和診所
    • 研究所
    • 製藥和生物技術公司
    • 學術機構
    • 其他
  • 市場規模及預測：依組件分類
    • 硬體
    • 軟體
    • 服務
    • 其他
  • 市場規模及預測：依功能分類
    • 資料管理
    • 數據解讀
    • 資料儲存
    • 其他
  • 市場規模及預測：依設備分類
    • 桌上型音序器
    • 可攜式音序器
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章 公司簡介

  • BGI Genomics
  • Novogene
  • Personalis
  • Gencove
  • Veritas Genetics
  • Macrogen
  • Roche Nimble Gen
  • Eurofins Genomics
  • Med Genome
  • Otogenetics
  • Admera Health
  • GATC Biotech
  • Sci Genom Labs
  • CD Genomics
  • Intellia Therapeutics
  • Genotypic Technology
  • Ce Ga T
  • Agilent Technologies
  • Centogene
  • Fulgent Genetics

第9章：關於我們

簡介目錄
Product Code: GIS10515

Whole Exome Sequencing Market is anticipated to expand from $14.4 billion in 2024 to $90.3 billion by 2034, growing at a CAGR of approximately 32.4%. The Whole Exome Sequencing Market encompasses the technology and services for sequencing all protein-coding regions of genes, known as exomes. This approach aids in identifying genetic variants associated with diseases, offering insights for personalized medicine. Advances in sequencing technology and decreasing costs are propelling market growth. The demand is driven by increasing research in genomics, rare disease diagnosis, and precision oncology, highlighting the need for innovation in data analysis and interpretation.

The Whole Exome Sequencing Market is experiencing robust growth, primarily driven by advancements in genomic research and personalized medicine. The services segment leads in performance, with diagnostic services and clinical research applications being pivotal. This is due to their role in identifying genetic disorders and informing treatment strategies. The products segment, particularly consumables such as kits and reagents, follows closely, reflecting the ongoing need for reliable and efficient sequencing processes. Within the services sub-segment, clinical diagnostics is anticipated to remain the top performer, fueled by increasing demand for precision medicine. Research applications, particularly in oncology, are the second highest performing sub-segment, driven by the need for detailed genetic insights. The rising adoption of whole exome sequencing in rare disease diagnosis further underscores its market potential. Technological advancements, such as improved sequencing accuracy and reduced costs, are expected to sustain market momentum, offering lucrative opportunities for industry stakeholders.

Market Segmentation
TypeTargeted Exome Sequencing, Whole Exome Sequencing
ProductKits, Reagents, Instruments, Software
ServicesSequencing Services, Data Analysis Services, Consultation Services
TechnologySequencing by Synthesis, Ion Semiconductor Sequencing, Nanopore Sequencing
ApplicationDiagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture and Animal Research
End UserHospitals and Clinics, Research Institutes, Pharmaceutical and Biotechnology Companies, Academic Institutions
ComponentHardware, Software, Services
FunctionalityData Management, Data Interpretation, Data Storage
DeviceBenchtop Sequencers, Portable Sequencers

The Whole Exome Sequencing market is witnessing a dynamic shift in market share, driven by advancements in genomic technologies and personalized medicine. Pricing strategies are increasingly competitive, with companies striving to offer cost-effective solutions without compromising on quality. New product launches are frequent, as firms innovate to meet the growing demand for precision diagnostics. The market landscape is characterized by a robust pipeline of next-generation sequencing platforms, reflecting a commitment to technological evolution and enhanced accessibility. Competition in the Whole Exome Sequencing market is fierce, with key players vying for dominance through strategic partnerships and acquisitions. Regulatory influences are significant, with stringent guidelines shaping market entry and operational standards. North America remains a pivotal region, bolstered by favorable regulatory frameworks and substantial R&D investments. Meanwhile, Asia-Pacific is emerging as a lucrative market, driven by government initiatives and increasing healthcare expenditure. The market is poised for growth, with opportunities arising from advancements in bioinformatics and expanded clinical applications.

Geographical Overview:

The Whole Exome Sequencing (WES) market is witnessing substantial growth across diverse regions, each presenting unique opportunities. North America leads the market, driven by advanced healthcare infrastructure and significant research investments. The region's focus on precision medicine and genomics further bolsters market expansion. Europe follows, with strong governmental support for genomic research and personalized medicine initiatives. The region's robust regulatory framework enhances the adoption of WES technologies. In Asia Pacific, rapid advancements in healthcare infrastructure and increased healthcare expenditure are fueling market growth. Countries like China and India are emerging as key players, investing heavily in genomic research. Latin America and the Middle East & Africa are nascent markets with promising potential. In Latin America, growing awareness and investments in genomic medicine are key drivers. The Middle East & Africa are recognizing the importance of genomics in addressing regional health challenges, positioning themselves as future growth pockets in the WES market.

The Whole Exome Sequencing Market is navigating a complex landscape shaped by global tariffs, geopolitical tensions, and evolving supply chain dynamics. In Japan and South Korea, companies are mitigating tariff impacts by investing in local research and development, aiming to reduce reliance on imported sequencing technologies. China's strategic pivot towards self-sufficiency in biotech tools is accelerated by trade restrictions, fostering domestic innovation. Taiwan, while a key player in semiconductor supply, faces geopolitical vulnerabilities that may affect its biotech sector. Globally, the market is robust, driven by advancements in precision medicine. By 2035, growth will hinge on regional collaborations and resilient supply chains. Additionally, ongoing Middle East conflicts could disrupt energy prices, indirectly influencing production costs and logistics within the sequencing industry.

Key Trends and Drivers:

The Whole Exome Sequencing Market is experiencing robust growth, driven by technological advancements and decreasing sequencing costs. This trend is making the technology more accessible to a broader range of research institutions and healthcare providers. Additionally, the rising prevalence of genetic disorders and personalized medicine initiatives is fueling demand for more precise and comprehensive genetic analysis. Another significant trend is the integration of artificial intelligence and machine learning in data analysis. These technologies enhance the interpretation of complex genetic data, providing insights that can lead to more effective treatments. Furthermore, collaborations between academic institutions and industry players are fostering innovation and accelerating the development of novel sequencing solutions. The increasing focus on rare disease research is another driver, as whole exome sequencing offers a powerful tool for identifying genetic mutations. Opportunities are also emerging in developing regions, where healthcare infrastructure is improving, and there is growing interest in advanced genetic testing. Companies that can offer cost-effective and scalable solutions are well-positioned to capture market share. As awareness of the benefits of genetic testing grows, the market is set for sustained expansion.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Component
  • 2.8 Key Market Highlights by Functionality
  • 2.9 Key Market Highlights by Device

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Targeted Exome Sequencing
    • 4.1.2 Whole Exome Sequencing
    • 4.1.3 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Kits
    • 4.2.2 Reagents
    • 4.2.3 Instruments
    • 4.2.4 Software
    • 4.2.5 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Sequencing Services
    • 4.3.2 Data Analysis Services
    • 4.3.3 Consultation Services
    • 4.3.4 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Sequencing by Synthesis
    • 4.4.2 Ion Semiconductor Sequencing
    • 4.4.3 Nanopore Sequencing
    • 4.4.4 Others
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Diagnostics
    • 4.5.2 Drug Discovery and Development
    • 4.5.3 Personalized Medicine
    • 4.5.4 Agriculture and Animal Research
    • 4.5.5 Others
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Hospitals and Clinics
    • 4.6.2 Research Institutes
    • 4.6.3 Pharmaceutical and Biotechnology Companies
    • 4.6.4 Academic Institutions
    • 4.6.5 Others
  • 4.7 Market Size & Forecast by Component (2020-2035)
    • 4.7.1 Hardware
    • 4.7.2 Software
    • 4.7.3 Services
    • 4.7.4 Others
  • 4.8 Market Size & Forecast by Functionality (2020-2035)
    • 4.8.1 Data Management
    • 4.8.2 Data Interpretation
    • 4.8.3 Data Storage
    • 4.8.4 Others
  • 4.9 Market Size & Forecast by Device (2020-2035)
    • 4.9.1 Benchtop Sequencers
    • 4.9.2 Portable Sequencers
    • 4.9.3 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Component
      • 5.2.1.8 Functionality
      • 5.2.1.9 Device
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Component
      • 5.2.2.8 Functionality
      • 5.2.2.9 Device
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Component
      • 5.2.3.8 Functionality
      • 5.2.3.9 Device
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Component
      • 5.3.1.8 Functionality
      • 5.3.1.9 Device
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Component
      • 5.3.2.8 Functionality
      • 5.3.2.9 Device
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Component
      • 5.3.3.8 Functionality
      • 5.3.3.9 Device
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Component
      • 5.4.1.8 Functionality
      • 5.4.1.9 Device
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Component
      • 5.4.2.8 Functionality
      • 5.4.2.9 Device
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Component
      • 5.4.3.8 Functionality
      • 5.4.3.9 Device
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Component
      • 5.4.4.8 Functionality
      • 5.4.4.9 Device
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Component
      • 5.4.5.8 Functionality
      • 5.4.5.9 Device
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Component
      • 5.4.6.8 Functionality
      • 5.4.6.9 Device
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Component
      • 5.4.7.8 Functionality
      • 5.4.7.9 Device
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Component
      • 5.5.1.8 Functionality
      • 5.5.1.9 Device
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Component
      • 5.5.2.8 Functionality
      • 5.5.2.9 Device
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Component
      • 5.5.3.8 Functionality
      • 5.5.3.9 Device
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Component
      • 5.5.4.8 Functionality
      • 5.5.4.9 Device
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Component
      • 5.5.5.8 Functionality
      • 5.5.5.9 Device
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Component
      • 5.5.6.8 Functionality
      • 5.5.6.9 Device
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Component
      • 5.6.1.8 Functionality
      • 5.6.1.9 Device
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Component
      • 5.6.2.8 Functionality
      • 5.6.2.9 Device
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Component
      • 5.6.3.8 Functionality
      • 5.6.3.9 Device
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Component
      • 5.6.4.8 Functionality
      • 5.6.4.9 Device
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Component
      • 5.6.5.8 Functionality
      • 5.6.5.9 Device

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 BGI Genomics
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Novogene
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Personalis
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Gencove
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Veritas Genetics
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Macrogen
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Roche Nimble Gen
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Eurofins Genomics
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Med Genome
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Otogenetics
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Admera Health
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 GATC Biotech
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Sci Genom Labs
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 CD Genomics
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Intellia Therapeutics
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Genotypic Technology
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Ce Ga T
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Agilent Technologies
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Centogene
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Fulgent Genetics
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us